Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (111-120 of 237) with videos related to

Pageof 24
Sort By:
International Journal of Biological Sciences|July 1, 2006
The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitorsJoseph A De Soto, Xianyan Wang, Yohei Tominaga, et al.
Journal of Medicinal Chemistry|December 5, 2008
Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)Jian-kang Jiang, Kamran Ghoreschi, Francesca Deflorian, et al.
Retrovirology|December 11, 2012
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutantsBarry C Johnson, Gary T Pauly, Ganesha Rai, et al.
Blood|November 26, 2010
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSPWei Ju, Meili Zhang, Jian-kang Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2025
Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemiaPatrick J Sutter, Morgan M Walker, Chris J Finocchio, et al.
Journal of Medicinal Chemistry|May 17, 2011
Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease HSuhman Chung, Daniel M Himmel, Jian-Kang Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 13, 2023
Preclinical validation of a novel therapeutic strategy for choroid plexus carcinomaBrice Martin, Tyler Garman, Madeline Laramee, et al.
Nature|September 30, 2017
Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade gliomaHumsa S Venkatesh, Lydia T Tam, Pamelyn J Woo, et al.
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Medchemcomm|March 13, 2012
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor AgonistsErika E Englund, Susanne Neumann, Elena Eliseeva, et al.
Pageof 24

Showing results (111-120 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Biological Sciences|July 1, 2006
The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitorsJoseph A De Soto, Xianyan Wang, Yohei Tominaga, et al.
Journal of Medicinal Chemistry|December 5, 2008
Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)Jian-kang Jiang, Kamran Ghoreschi, Francesca Deflorian, et al.
Retrovirology|December 11, 2012
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutantsBarry C Johnson, Gary T Pauly, Ganesha Rai, et al.
Blood|November 26, 2010
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSPWei Ju, Meili Zhang, Jian-kang Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2025
Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemiaPatrick J Sutter, Morgan M Walker, Chris J Finocchio, et al.
Journal of Medicinal Chemistry|May 17, 2011
Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease HSuhman Chung, Daniel M Himmel, Jian-Kang Jiang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 13, 2023
Preclinical validation of a novel therapeutic strategy for choroid plexus carcinomaBrice Martin, Tyler Garman, Madeline Laramee, et al.
Nature|September 30, 2017
Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade gliomaHumsa S Venkatesh, Lydia T Tam, Pamelyn J Woo, et al.
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Medchemcomm|March 13, 2012
The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor AgonistsErika E Englund, Susanne Neumann, Elena Eliseeva, et al.
Pageof 24